Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TAMOXIFEN Cause Carbohydrate antigen 125 increased? 17 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Carbohydrate antigen 125 increased have been filed in association with TAMOXIFEN (Tamoxifen Citrate). This represents 0.2% of all adverse event reports for TAMOXIFEN.

17
Reports of Carbohydrate antigen 125 increased with TAMOXIFEN
0.2%
of all TAMOXIFEN reports
2
Deaths
1
Hospitalizations

How Dangerous Is Carbohydrate antigen 125 increased From TAMOXIFEN?

Of the 17 reports, 2 (11.8%) resulted in death, 1 (5.9%) required hospitalization, and 1 (5.9%) were considered life-threatening.

Is Carbohydrate antigen 125 increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TAMOXIFEN. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does TAMOXIFEN Cause?

Malignant neoplasm progression (1,499) Metastases to bone (894) Fatigue (729) Nausea (611) Metastases to liver (595) Breast cancer (584) Disease progression (571) Breast cancer metastatic (515) Diarrhoea (512) Arthralgia (497)

What Other Drugs Cause Carbohydrate antigen 125 increased?

NIRAPARIB (1,868) RUCAPARIB CAMSYLATE (562) OLAPARIB (280) BEVACIZUMAB (141) LETROZOLE (61) CARBOPLATIN (54) PACLITAXEL (50) DOXORUBICIN (43) PEMBROLIZUMAB (36) COVID-19 VACCINE NOS (27)

Which TAMOXIFEN Alternatives Have Lower Carbohydrate antigen 125 increased Risk?

TAMOXIFEN vs TAMSULOSIN TAMOXIFEN vs TAPENTADOL TAMOXIFEN vs TAPINAROF TAMOXIFEN vs TARCEVA TAMOXIFEN vs TARLATAMAB

Related Pages

TAMOXIFEN Full Profile All Carbohydrate antigen 125 increased Reports All Drugs Causing Carbohydrate antigen 125 increased TAMOXIFEN Demographics